BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 34390506)

  • 1. Spectrum of hematological malignancies, clonal evolution and outcomes in 144 Mayo Clinic patients with germline predisposition syndromes.
    Martin ES; Ferrer A; Mangaonkar AA; Khan SP; Kohorst MA; Joshi AY; Hogan WJ; Olteanu H; Moyer AM; Al-Kali A; Tefferi A; Chen D; Wudhikarn K; Go R; Viswanatha D; He R; Ketterling R; Nguyen PL; Oliveira JL; Gangat N; Lasho T; Patnaik MM
    Am J Hematol; 2021 Nov; 96(11):1450-1460. PubMed ID: 34390506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hereditary Predisposition to Hematopoietic Neoplasms: When Bloodline Matters for Blood Cancers.
    Mangaonkar AA; Patnaik MM
    Mayo Clin Proc; 2020 Jul; 95(7):1482-1498. PubMed ID: 32571604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary myeloid malignancies.
    Rafei H; DiNardo CD
    Best Pract Res Clin Haematol; 2019 Jun; 32(2):163-176. PubMed ID: 31203998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency and natural history of inherited bone marrow failure syndromes: the Israeli Inherited Bone Marrow Failure Registry.
    Tamary H; Nishri D; Yacobovich J; Zilber R; Dgany O; Krasnov T; Aviner S; Stepensky P; Ravel-Vilk S; Bitan M; Kaplinsky C; Ben Barak A; Elhasid R; Kapelusnik J; Koren A; Levin C; Attias D; Laor R; Yaniv I; Rosenberg PS; Alter BP
    Haematologica; 2010 Aug; 95(8):1300-7. PubMed ID: 20435624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The International Consensus Classification (ICC) of hematologic neoplasms with germline predisposition, pediatric myelodysplastic syndrome, and juvenile myelomonocytic leukemia.
    Rudelius M; Weinberg OK; Niemeyer CM; Shimamura A; Calvo KR
    Virchows Arch; 2023 Jan; 482(1):113-130. PubMed ID: 36445482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Patients and Families With Concern for Predispositions to Hematologic Malignancies Within the Hereditary Hematologic Malignancy Clinic (HHMC).
    DiNardo CD; Bannon SA; Routbort M; Franklin A; Mork M; Armanios M; Mace EM; Orange JS; Jeff-Eke M; Churpek JE; Takahashi K; Jorgensen JL; Garcia-Manero G; Kornblau S; Bertuch A; Cheung H; Bhalla K; Futreal A; Godley LA; Patel KP
    Clin Lymphoma Myeloma Leuk; 2016 Jul; 16(7):417-428.e2. PubMed ID: 27210295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic predisposition to MDS: clinical features and clonal evolution.
    Kennedy AL; Shimamura A
    Blood; 2019 Mar; 133(10):1071-1085. PubMed ID: 30670445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic predisposition syndromes: when should they be considered in the work-up of MDS?
    Babushok DV; Bessler M
    Best Pract Res Clin Haematol; 2015 Mar; 28(1):55-68. PubMed ID: 25659730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic characterization of the inherited bone marrow failure syndromes.
    Khincha PP; Savage SA
    Semin Hematol; 2013 Oct; 50(4):333-47. PubMed ID: 24246701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of somatic transformation in inherited bone marrow failure syndromes.
    Choijilsuren HB; Park Y; Jung M
    Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):390-398. PubMed ID: 34889377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germline predisposition in myeloid neoplasms: Unique genetic and clinical features of GATA2 deficiency and SAMD9/SAMD9L syndromes.
    Sahoo SS; Kozyra EJ; Wlodarski MW
    Best Pract Res Clin Haematol; 2020 Sep; 33(3):101197. PubMed ID: 33038986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline CHEK2 and ATM Variants in Myeloid and Other Hematopoietic Malignancies.
    Stubbins RJ; Korotev S; Godley LA
    Curr Hematol Malig Rep; 2022 Aug; 17(4):94-104. PubMed ID: 35674998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inherited thrombocytopenia and platelet disorders with germline predisposition to myeloid neoplasia.
    Galera P; Dulau-Florea A; Calvo KR
    Int J Lab Hematol; 2019 May; 41 Suppl 1():131-141. PubMed ID: 31069978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inherited bone marrow failure syndromes in adolescents and young adults.
    Wilson DB; Link DC; Mason PJ; Bessler M
    Ann Med; 2014 Sep; 46(6):353-63. PubMed ID: 24888387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical utility of targeted next-generation sequencing for the diagnosis of myeloid neoplasms with germline predisposition.
    Andrés-Zayas C; Suárez-González J; Rodríguez-Macías G; Dorado N; Osorio S; Font P; Carbonell D; Chicano M; Muñiz P; Bastos M; Kwon M; Díez-Martín JL; Buño I; Martínez-Laperche C
    Mol Oncol; 2021 Sep; 15(9):2273-2284. PubMed ID: 33533142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic tumor sequencing panels frequently identify germ line variants associated with hereditary hematopoietic malignancies.
    Drazer MW; Kadri S; Sukhanova M; Patil SA; West AH; Feurstein S; Calderon DA; Jones MF; Weipert CM; Daugherty CK; Ceballos-López AA; Raca G; Lingen MW; Li Z; Segal JP; Churpek JE; Godley LA
    Blood Adv; 2018 Jan; 2(2):146-150. PubMed ID: 29365323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De Novo Mutations Activating Germline TP53 in an Inherited Bone-Marrow-Failure Syndrome.
    Toki T; Yoshida K; Wang R; Nakamura S; Maekawa T; Goi K; Katoh MC; Mizuno S; Sugiyama F; Kanezaki R; Uechi T; Nakajima Y; Sato Y; Okuno Y; Sato-Otsubo A; Shiozawa Y; Kataoka K; Shiraishi Y; Sanada M; Chiba K; Tanaka H; Terui K; Sato T; Kamio T; Sakaguchi H; Ohga S; Kuramitsu M; Hamaguchi I; Ohara A; Kanno H; Miyano S; Kojima S; Ishiguro A; Sugita K; Kenmochi N; Takahashi S; Eto K; Ogawa S; Ito E
    Am J Hum Genet; 2018 Sep; 103(3):440-447. PubMed ID: 30146126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study.
    Alter BP; Giri N; Savage SA; Peters JA; Loud JT; Leathwood L; Carr AG; Greene MH; Rosenberg PS
    Br J Haematol; 2010 Jul; 150(2):179-88. PubMed ID: 20507306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inherited bone marrow failure syndromes and germline predisposition to myeloid neoplasia: A practical approach for the pathologist.
    Li J; Bledsoe JR
    Semin Diagn Pathol; 2023 Nov; 40(6):429-442. PubMed ID: 37507252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myelodysplastic neoplasms evolving from inherited bone marrow failure syndromes / germline predisposition syndromes: Back under the microscope.
    Elghetany MT; Patnaik MM; Khoury JD
    Leuk Res; 2024 Feb; 137():107441. PubMed ID: 38301422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.